Risk of HCC: Genetic heterogeneity and complex genetics

被引:168
作者
Dragani, Tommaso A. [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, I-20133 Milan, Italy
关键词
Cirrhosis; Glycogen storage disease; Hemochromatosis; Hepatitis; Non-alcoholic steatohepatitis; Porphyrias; Tyrosinemia type 1; PORPHYRIA-CUTANEA-TARDA; PRIMARY LIVER-CANCER; PRIMARY HEPATOCELLULAR-CARCINOMA; DISEASE TYPE-I; HEREDITARY HEMOCHROMATOSIS; HEPATITIS-B; FOLLOW-UP; VIRAL-HEPATITIS; HEPATOCARCINOGENESIS; SUSCEPTIBILITY;
D O I
10.1016/j.jhep.2009.11.015
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common form of cancer that arises from hepatocytes and whose risk may be affected by several known environmental factors, including hepatitis viruses, alcohol, cigarette smoking, and others. Rare monogenic syndromes, such as alphal-antitrypsin deficiency, glycogen storage disease type 1, hemochromatosis, acute intermittent and cutanea tarda porphyria, as well as hereditary tyrosinemia type I are associated with a high risk of HCC. Several common conditions or diseases inherited as polygenic traits e.g. autoimmune hepatitis, type 2 diabetes, a family history of HCC, hypothyroidism, and non-alcoholic steatohepatitis also show an increased risk of HCC compared to the general Population. Overall, the genetic susceptibility to HCC is characterized by a genetic heterogeneity; a high individual risk of HCC may thus be caused by several unlinked single gene defects, whose carriers are rare in the general Population, or by more common conditions inherited by complex genetics. (C) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 74 条
  • [1] Familial and Sporadic Porphyria Cutanea Tarda: Characterization and Diagnostic Strategies
    Aarsand, Aasne K.
    Boman, Helge
    Sandberg, Sverre
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 795 - 803
  • [2] Excess risk of primary liver cancer in patients with diabetes mellitus
    Adami, HO
    Chow, WH
    Nyren, O
    Berne, C
    Linet, MS
    Ekbom, A
    Wolk, A
    McLaughlin, JK
    Fraumeni, JF
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) : 1472 - 1477
  • [3] HFE-associated hereditary hemochromatosis
    Alexander, Jacob
    Kowdley, Kris V.
    [J]. GENETICS IN MEDICINE, 2009, 11 (05) : 307 - 313
  • [4] Hepatocellular carcinoma in patients with acute hepatic porphyria:: frequency of occurrence and related factors
    Andant, C
    Puy, H
    Bogard, C
    Faivre, J
    Soulé, JC
    Nordmann, Y
    Deybach, JC
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 (06) : 933 - 939
  • [5] [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V59, P1
  • [6] [Anonymous], 2002, IARC MONOGRAPHS EVAL, V82, P171, DOI DOI 10.1016/J.CHEMOSPHERE.2009.12.012
  • [7] [Anonymous], 2004, INT AGENCY RES CANC, V83, P1
  • [8] Carcinogenicity of alcoholic beverages
    Baan, Robert
    Straif, Kurt
    Grosse, Yann
    Secretan, Beatrice
    El Ghissassi, Fatiha
    Bouvard, Veronique
    Altieri, Andrea
    Cogliano, Vincent
    [J]. LANCET ONCOLOGY, 2007, 8 (04) : 292 - 293
  • [9] Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives
    Badenas, C.
    To-Figueras, J.
    Phillips, J. D.
    Warby, C. A.
    Munoz, C.
    Herrero, C.
    [J]. CLINICAL GENETICS, 2009, 75 (04) : 346 - 353
  • [10] BEAND K, 2009, WORLD J GASTROENTERO, V15, P1025